Mirtazapine Starting Dose for Adults
The recommended starting dose of mirtazapine is 15 mg once daily, administered orally in the evening prior to sleep. 1
Initial Dosing Protocol
- Begin with 15 mg once daily at bedtime as the standard starting dose for all adults 1, 2, 3
- Evening administration is specifically recommended to leverage the drug's sedative properties, which can help address sleep disturbances that commonly accompany depression 4
- The 15 mg starting dose should be maintained for at least 1-2 weeks before considering dose adjustments 1
Dose Titration Strategy
- If inadequate response occurs after 1-2 weeks at 15 mg, increase the dose up to a maximum of 45 mg per day 1
- Dose changes should not be made in intervals shorter than 1-2 weeks to allow sufficient time for evaluation of therapeutic response 1
- The effective daily dosage range is 15-45 mg, with most patients responding within this range 2, 3
Timeline for Clinical Response
- Begin assessing therapeutic response and adverse effects within 1-2 weeks of treatment initiation 5
- Sleep disturbances and anxiety symptoms may improve within the first week of treatment, though full antidepressant effect typically requires 2-4 weeks 2, 6
- If the patient does not have an adequate response within 6-8 weeks, treatment modification is strongly recommended 5
Special Clinical Considerations
- Mirtazapine is particularly effective for patients with depression accompanied by insomnia, anorexia, or weight loss due to its sedating properties and appetite-stimulating effects 5
- The drug has a faster onset of action than some SSRIs (fluoxetine, paroxetine, sertraline) 5
- Exercise caution in patients with obstructive sleep apnea, as mirtazapine may worsen this condition 4
Common Pitfalls to Avoid
- Do not start below 15 mg - some older literature suggested starting at lower doses, but current FDA labeling clearly establishes 15 mg as the appropriate starting dose 1
- Do not increase doses too rapidly - allow the full 1-2 weeks between dose adjustments to properly assess response 1
- Screen for bipolar disorder before initiating treatment, as antidepressants can precipitate manic episodes in susceptible patients 1
- Gradually taper rather than abruptly discontinue to minimize withdrawal symptoms 1
Drug Interactions Requiring Dose Modification
- Decrease mirtazapine dose when co-administering with strong CYP3A4 inhibitors (ketoconazole, clarithromycin) or cimetidine 1
- Increase mirtazapine dose when co-administering with strong CYP3A inducers (carbamazepine, phenytoin, rifampin) 1
- Allow at least 14 days between discontinuing an MAOI and starting mirtazapine, and vice versa 1
Expected Side Effects at Starting Dose
- Somnolence/sedation is common and may actually be more pronounced at lower doses 2, 6
- Increased appetite and weight gain occur more frequently than with placebo 2, 3
- Dry mouth is a common side effect 5
- The drug has minimal cardiovascular, anticholinergic, and sexual dysfunction side effects compared to tricyclic antidepressants and SSRIs 2, 6